Why PTC Therapeutics Dropped 30.6% Today After Jumping 27.5% Yesterday

Yesterday, PTC Therapeutics (NASDAQ:PTCT) jumped 27.5% following positive data for its spinal muscular atrophy drug, risdiplam, which sent shares of competitors Biogen and Ionis Pharmaceuticals down on the news.